Tempus AI, Inc.’s Lock-Up Period Set To End on December 11th (NASDAQ:TEM)

Tempus AI’s (NASDAQ:TEM) lock-up period will expire on Wednesday, December 11th. Tempus AI had issued 11,100,000 shares in its initial public offering on June 14th. The total size of the offering was $410,700,000 based on an initial share price of $37.00. After the expiration of the company’s lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. Piper Sandler reiterated a “neutral” rating and set a $70.00 target price (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Loop Capital raised their target price on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. JPMorgan Chase & Co. raised their price target on Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Finally, Bank of America downgraded shares of Tempus AI from a “buy” rating to a “neutral” rating and boosted their target price for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $54.22.

Tempus AI Price Performance

Tempus AI stock opened at $56.29 on Wednesday. Tempus AI has a 1 year low of $22.89 and a 1 year high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The firm has a 50-day moving average of $53.41.

Institutional Investors Weigh In On Tempus AI

Several institutional investors have recently bought and sold shares of TEM. NEA Management Company LLC raised its holdings in shares of Tempus AI by 17.8% in the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after buying an additional 813,169 shares during the last quarter. Novo Holdings A S acquired a new stake in Tempus AI in the second quarter valued at approximately $142,605,000. Revolution Growth Management Company Inc. purchased a new stake in Tempus AI in the 2nd quarter worth $128,133,000. ARK Investment Management LLC raised its position in shares of Tempus AI by 355.0% during the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after purchasing an additional 1,855,459 shares during the last quarter. Finally, Alphabet Inc. acquired a new position in shares of Tempus AI during the second quarter valued at approximately $54,289,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.